Dr. David J. Park, MD

Dr. Park practices at St. Jude Medical Center - Unit in Fullerton, California.

Dr. Park's NPI, 1275619447, was assigned on October 31, 2006. Dr. Park graduated from Icahn School Of Medicine At Mount Sinai in 1999. Dr. Park's California license number on file is A75876.

Dr. Park's primary practice is St. Jude Medical Center - Unit, at 101 E. Valencia Mesa Drive, Fullerton, CA 92835 in Orange County. The practice phone is (714) 578-8706.

Dr. Park's primary practice is St. Jude Medical Center - Unit in Fullerton, California. Dr. Park is also affiliated with Providence St. Jude Medical Center. The medical group on file is St. Jude Heritage Medical Group. Dmand AI also links Dr. Park to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Park practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Park's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Park is board certified in hematology by the American Board of Internal Medicine. Dr. Park has a license on file in California.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer and lymphoma among the conditions Dr. Park treats.

CMS data shows 1,576 Medicare services from Dr. Park across 11 procedure codes in 2024, for 409 Medicare patients. Medicare paid $141,406 for them.

CMS counts 409 Medicare patients who saw Dr. Park in 2024. The largest group is 65 to 74, with 169 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 15% are also on Medicaid. Their average risk score is 2.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Park's median patient age at 67, with 70% women.

In 2024, Dr. Park wrote 1,286 Medicare Part D claims for 313 patients. 79% of them were for generic drugs. CMS names the drug for 936 of them, across 22 drugs with 11 or more claims each, at $836,341 in total drug cost. In 2023, CMS named 1,129 claims across 32 drugs.

Dr. Park accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Park as offering telehealth.

Dmand AI links 76 papers to Dr. Park, published from 2006 to 2025. 2024 was the busiest year, with 22. The most frequent topics are Radiosurgery, Brain Neoplasms and Spinal Neoplasms. Dr. Park has published most often in J Neurosurg Case Lessons. Dr. Park's most frequent co-authors are David Jaehyun Park, MD, PhD, Steven Daniel Chang, MD and Yusuke Hori, MD.

Dmand AI links Dr. Park to 1 clinical trial. Conditions studied include Pancreatic Neoplasms and Pancreatic Diseases. Open Payments lists research payments to Dr. Park that name 1 trial.

CMS Open Payments shows 818 general payments to Dr. Park from 68 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 61% of the total. AstraZeneca Pharmaceuticals LP paid the most, $42,478. It also lists 1 research payment totaling $132 in 2019, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Park, most recently CMS Stage 1 EHR in 2012.

Dr. Park graduated from Icahn School Of Medicine At Mount Sinai in 1999. Dr. Park is a member of ASCO.

Dr. Park is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.